Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. (United States) holds 0 active US FDA Type II Drug Master Files and 74 inactive, has DMF or CEP filings on record for 4 active ingredients, holds 3 active Type IV (excipient) Drug Master Files and is linked to 14 FDA-registered manufacturing sites. 18 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Catalent Pharma Solutions, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/catalent-pharma-solutions-inc
Overview
Catalent Pharma Solutions, Inc. is a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, and consumer health products. With a strong focus on innovation and customer partnership, Catalent enables better treatments across more than 50 countries worldwide.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Catalent Pharma Solutions, Inc. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Catalent Pharma Solutions, Inc. holds 0 active (74 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- SOFTGELS [OET 10275449 50]Inactive2019-04-11
- SOFTGELS [OET - 10258984]Inactive2018-10-22
- SOFTGELS [OET-10275547-9]Inactive2018-09-28
- SOFTGELS [OET - 10275485]Inactive2017-12-15
- SOFTGELS [OET: 10275427-9]Inactive2017-11-14
- SOFTGELS [OET-10275412]Inactive2017-05-26
- SOFTGELS [OET-10259015-17]Inactive2017-04-13
- SOFTGELS [OET-10258867]Inactive2016-10-20
- SOFTGELS [OET-10259014]Inactive2016-06-24
- SOFTGELS [OET- 10275405-7]Inactive2016-06-21
- SOFTGELS [OET-10275378]Inactive2015-12-15
- SOFTGELS [OET-10275191]Inactive2015-01-16
- SOFTGELS [OET-10275198]Inactive2014-10-22
- SOFTGELS [OET-10275268]Inactive2014-03-24
- SOFTGELS [OET-00775174]Inactive2013-12-12
- SOFTGELS [OET-10275266]Inactive2013-12-06
- SOFTGELS [OET-10275282]Inactive2013-10-30
- SOFTGELS [OET-10275226]Inactive2013-10-24
- SOFTGELS [OET-10275265]Inactive2013-06-24
- SOFTGELS [OET-10275261]Inactive2013-03-26
- SOFTGELS [OET-10275260]Inactive2013-01-15
- SOFTGEL CAPSULE [OET-10275263]Inactive2013-01-15
- SOFT GELATIN CAPSULE - OET-10275258Inactive2012-12-31
- PALONOSETRON HC1 0.50 MG SOFTGELS (1.5 OVAL)Inactive2012-09-18
- WC3042-05, CAPSULEInactive2012-05-31
- WC3042-08P CAPSULEInactive2012-05-31
- MDV3100, 40MG, CAPSULES (SOFTGELS)Inactive2012-02-22
- AMR101 1G CAPSULESInactive2011-09-12
- SOFTGELS [OET - 10258977]Inactive2010-12-17
- SOFT GELATIN CAPSULE MANUFACTURING PROCESS FOR OET-10275167Inactive2010-12-10
- DUTASTERIDE 0.5 MG SOFT GELATIN CAPSULESInactive2010-10-19
- SOFTGELS [0775279]Inactive2010-09-01
- DRONABINOL CAPSULES USP 2.5MG, 5.0MG, 10.0MG (CIII) SAInactive2010-05-27
- PROGESTERONE SOFT GELATIN CAPSULES 100 MG AND 200 MGInactive2010-05-21
- PROCARDIA SOFTGELS 10 MG (NIFEDIPINE)Inactive2009-09-18
- ESTRADIOL VAGINAL SOFT GELATIN CAPSULESInactive2009-06-08
- MICONAZOLE 1200 MG SOFTGELSInactive2007-06-22
- MICONAZOLE GELATIN ENCAPSULATED VAGINAL SUPPOSITORY 200 MGInactive2006-11-08
- SANDIMMUNE 25 MG AND 100 MG SOFTGELSInactive2005-11-30
- R115866 SOFTGELSInactive2005-08-26
- LORATADINE SOFTGELS (10 MG)Inactive2005-08-23
- NIMODIPINE 30MG SOFTGELSInactive2005-05-24
- NEORAL 25 MG AND 100 MG SOFTGELSInactive2005-04-13
- PALONOSETRON HYDROCHLORIDE 0.50 MG SOFTGELSInactive2005-03-17
- LUBIPROSTONE, 24 MCG CAPSULESInactive2005-02-11
- TIPRANAVIR CAPSULES 250 MG (IMPRINTED)Inactive2004-10-26
- ATRASENTAN HYDROCHLORIDE, SOFT GELATIN CAPSULES, 10 MG (BASE EQUIVALENT)Inactive2004-09-05
- ZEMPLAR (PARACALCITOL) CAPSULES, 1 MCGInactive2004-05-20
- RISPERIDONE 2.0 MG ORALLY DISINTEGRATING TABLETSInactive2004-03-24
- CALCITRIOL 0.25 MCG SOFT GELATIN CAPSULESInactive2003-11-20
Showing the 50 most relevant of 74 Drug Master Files (active first). The full list is in the FDA DMF list.
Excipient Drug Master Files
Catalent Pharma Solutions, Inc. holds 3 active (6 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.
- PLANT BASED SHELLActive2022-10-13
- GELATIN MASS FOR SOFTGEL CAPSULESActive2020-06-02
- GELATIN MASS FOR SOFTGELSActive2020-03-27
- SOFTGELS [OET 10275375-7]Inactive2016-05-19
- SOFTGELS [OET-10275299]Inactive2014-11-03
- GELATIN MASSESInactive2010-08-02
Registered manufacturing sites (14)
Physical sites registered with the US FDA and resolved to Catalent Pharma Solutions, Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
- CATALENT ARGENTINA S.A.I.C.Buenos Aires, Argentina · Analytical testing · Drug manufactureSite GMP match
- Catalent CTS (Edinburgh) LimitedEdinburgh, United Kingdom · Labelling · Packaging
- Catalent France Beinheim SABeinheim, France · Analytical testing · Drug manufacture
- CATALENT FRANCE LIMOGES SASLIMOGES, France · Analytical testing · Drug manufactureSite GMP match
- Catalent Germany Eberbach GmbHEberbach, Germany · Analytical testing · Drug manufactureSite GMP match
- Catalent Germany Schorndorf GmbHSchorndorf, Germany · Analytical testing · LabellingSite GMP match
- Catalent Maryland, Inc.Harmans, United States · API manufactureSite GMP match
- Catalent Maryland, Inc.Baltimore, United States · Analytical testing · Drug manufactureSite GMP match
- Catalent Micron Technologies LtdDartford, United Kingdom · Analytical testing · Particle size reductionSite GMP match
- Catalent Micron Technologies, Inc.Malvern, United States · Analytical testing · Particle size reduction
- Catalent Pharma Solutions, LLCWinchester, United States · Analytical testing · Labelling
- Catalent Pharma Solutions, LLCMadison, United States · API manufactureSite GMP match
- Catalent Pharma Solutions, LLCPhiladelphia, United States · Labelling · Packaging
- CATALENT U.K. SWINDON ZYDIS LIMITEDSwindon, United Kingdom · Analytical testing · Drug manufactureSite GMP match
FDA compliance signals
18 FDA enforcement records linked to this company.
- 4832026-05-22
Written procedures not established/followed
- 4832025-04-22
Investigations of discrepancies, failures
- 4832025-04-22
Written procedures not established/followed
- 4832024-05-24
Cleaning / Sanitizing / Maintenance
- 4832023-01-11
Second person sign off
- 4832022-12-15
Sterility/pyrogens - test methods written, followed
- 4832022-12-15
Following/documenting laboratory controls
- 4832022-12-15
Establishment of calibration procedures
- 4832022-12-15
Test methods
- 4832019-02-22
Scientifically sound laboratory controls
- 4832019-02-22
Written program not followed
- 4832019-02-22
SOPs not followed / documented
- 4832018-06-14
Procedures for non-sterile drug products
- 4832018-06-14
Written in-process control procedures
- 4832018-06-14
Procedures not in writing, fully followed
- 4832018-06-14
Quality control unit review of records
- 4832017-05-19
Released Drug Products Area
- 4832017-05-19
Procedures not in writing, fully followed
Is this Catalent Pharma Solutions, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.